Tag: dostarlimab

Neoadjuvant dostarlimab is a promising treatment option in locally advanced dMMR rectal cancer

byJohan Pushaniand1 others

June 13, 2022

1. All neoadjuvant dostarlimab patients had a clinical complete response and no patients needed any additional treatments at the study ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Prognostic associations of anthropometric indices vary by clinical outcomes
Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma
Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome

No Result

View All Result

Tag: dostarlimab

Neoadjuvant dostarlimab is a promising treatment option in locally advanced dMMR rectal cancer

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits